Pykus Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A2

  • Investors
  • 10

Pykus Therapeutics General Information

Description

Operator of a medical technology company intended to develop biodegradable polymers for unmet needs in vitreoretinal surgery. The company provides a novel biodegradable hydrogel to replace the use of intraocular gas and eliminates the need for retina positioning, enabling surgeons to access material to recover from retina surgery faster and more comfortably.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1000 Massachusetts Avenue
  • Suite 101
  • Cambridge, MA 02138
  • United States
+1 (617)
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1000 Massachusetts Avenue
  • Suite 101
  • Cambridge, MA 02138
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pykus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A2) 01-Jul-2024 Completed Clinical Trials - Phase 1
7. Later Stage VC (Series A) 04-Feb-2021 Completed Clinical Trials - Phase 1
6. Early Stage VC (Series A) 11-Jun-2018 Completed Clinical Trials - Phase 1
5. Angel (individual) Cancelled Clinical Trials - Phase 1
4. Accelerator/Incubator 23-May-2017 Completed Clinical Trials - Phase 1
3. Accelerator/Incubator Completed Startup
2. Grant 04-May-2016 $25K $5K Completed Startup
1. Accelerator/Incubator 09-Mar-2016 $5K $5K Completed Startup
To view Pykus Therapeutics’s complete valuation and funding history, request access »

Pykus Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Pykus Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Pykus Therapeutics Patents

Pykus Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12233157-B1 Hydrogel formulations and methods and devices for administration of the same Active 24-Jul-2024
WO-2026024285-A1 Hydrogel formulations and methods and devices for administration of the same Pending 24-Jul-2024
US-11883378-B2 Hydrogel formulations and methods and devices for focal administration of the same Active 24-Nov-2021
US-20230157988-A1 Hydrogel formulations and methods and devices for focal administration of the same Active 24-Nov-2021
WO-2023097213-A1 Hydrogel formulations and methods and devices for focal administration of the same Inactive 24-Nov-2021 A61K31/795
To view Pykus Therapeutics’s complete patent history, request access »

Pykus Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pykus Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
SideCar Angels Angel Group Minority
Hongsen Investment Venture Capital Minority
Astellas Venture Management Corporate Venture Capital Minority
Beacon Angels Angel Group Minority
Mass General Brigham Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Pykus Therapeutics FAQs

  • When was Pykus Therapeutics founded?

    Pykus Therapeutics was founded in 2016.

  • Where is Pykus Therapeutics headquartered?

    Pykus Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Pykus Therapeutics?

    Pykus Therapeutics has 8 total employees.

  • What industry is Pykus Therapeutics in?

    Pykus Therapeutics’s primary industry is Surgical Devices.

  • Is Pykus Therapeutics a private or public company?

    Pykus Therapeutics is a Private company.

  • What is Pykus Therapeutics’s current revenue?

    The current revenue for Pykus Therapeutics is .

  • How much funding has Pykus Therapeutics raised over time?

    Pykus Therapeutics has raised $11.6M.

  • Who are Pykus Therapeutics’s investors?

    SideCar Angels, Hongsen Investment, Astellas Venture Management, Beacon Angels, and Mass General Brigham Ventures are 5 of 10 investors who have invested in Pykus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process